Literature DB >> 14972490

Late urologic effects after adjuvant irradiation in stage I endometrial carcinoma.

R Herwig1, F Bruns, H Strasser, Germar M Pinggera, O Micke, P Rehder, C Gozzi, N Willich, L Hertle.   

Abstract

OBJECTIVES: To evaluate the incidence and type of incontinence after external beam radiotherapy (RT) and brachytherapy. Distinct late effects on the urinary bladder can occur and are frequently mild after adjuvant RT for Stage I endometrial carcinoma. Not all side effects that impair quality of life (eg, urinary incontinence) are classified in the commonly used grading system.
METHODS: Forty-one patients were evaluated for newly occurred urinary incontinence after adjuvant RT. The mean follow-up was 64.8 months, and the mean age was 62.1 years. The validated incontinence score from Gaudenz was used. Additionally, quality-of-life questions were asked.
RESULTS: Overall, 22 (53.7%) of 41 patients complained of urinary incontinence. Urge incontinence was classified in 45.5% (10 of 22 patients) and stress urinary incontinence in 54.5% (12 of 22 patients).
CONCLUSIONS: The onset of stress urinary incontinence after brachytherapy can be explained by anatomic findings, such as adverse affects to the nerve supply of the rhabdosphincter. According to our results, the exposure to additional external beam RT can cause urge incontinence. Patients and doctors must be aware that urinary incontinence, with an occurrence rate of more than 50%, represents the most common side effect after surgery and RT for Stage I endometrial carcinoma. We conclude that, depending on the type of RT, a stress incontinence rate of 24.4% and an urge incontinence rate of 29.2% is possible.

Entities:  

Mesh:

Year:  2004        PMID: 14972490     DOI: 10.1016/j.urology.2003.09.040

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study.

Authors:  Sean Soisson; Patricia A Ganz; David Gaffney; Kerry Rowe; John Snyder; Yuan Wan; Vikrant Deshmukh; Mike Newman; Alison Fraser; Ken Smith; Kimberly Herget; Heidi A Hanson; Yelena P Wu; Joseph Stanford; Theresa L Werner; Veronica Wendy Setiawan; Mia Hashibe
Journal:  Gynecol Oncol       Date:  2017-12-27       Impact factor: 5.482

2.  Urinary symptoms and impact on quality of life in women after treatment for endometrial cancer.

Authors:  E A Erekson; V W Sung; P A DiSilvestro; D L Myers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-11-05

3.  Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy.

Authors:  Alexandra J Stewart; Robert A Cormack; Hang Lee; Li Xiong; Jorgen L Hansen; Desmond A O'Farrell; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-18       Impact factor: 7.038

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.